U.S. Healthcare Services Stock News

NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Riverside Partnership in Ultra Secure Defense Hardware Could Be A Game Changer For Plexus (PLXS)

In May 2026, Riverside Research announced a partnership with Plexus Corp. to co-develop reusable modular hardware and software for ultra-secure, connected devices serving intelligence and defense customers, debuting the Aegis R52L Enhanced Retransmission Device after moving from concept to full-scale manufacturing plans in under nine months. This collaboration highlights Plexus’s ability to combine rapid prototyping with complex, regulated-market manufacturing, potentially strengthening its...
NasdaqGS:EBC
NasdaqGS:EBCBanks

Assessing Eastern Bankshares (EBC) Valuation After Cambridge Trust Merger And Recent Share Performance

Eastern Bankshares overview and recent share performance Eastern Bankshares (EBC) has been drawing attention after a period of mixed short term returns, with the stock roughly flat over the past month and slightly lower over the past 3 months. That recent trading contrasts with stronger longer term figures. These include a 1 year total return of 38.4%, a 3 year total return that is described as very large, and a modest 5 year total return of 1.0%. See our latest analysis for Eastern...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Assessing Trimble (TRMB) Valuation After Project Pressure’s Glacier Mapping Highlights Its Positioning Technology

Trimble (TRMB) is back in focus after its positioning technology underpinned Project Pressure’s latest Melting Topics expedition in Papua, Indonesia, producing a centimeter accurate 3D model of rapidly disappearing equatorial glaciers. See our latest analysis for Trimble. That field success has not translated into recent share price strength. Trimble’s stock is at US$56.34 after a 1-day share price return of 0.66% and a 7-day share price return of 2.40%. This compares with a 30-day share...
NYSE:NSA
NYSE:NSASpecialized REITs

A Look At National Storage Affiliates (NSA) Valuation After Strong Recent Total Returns

Market snapshot and recent performance National Storage Affiliates Trust (NSA) has been drawing attention after recent trading, with the stock last closing at $42.71. It has shown mixed short term moves alongside stronger longer term total returns. Over the past day the stock declined 0.16%, while it gained 4.12% over the past week and fell 1.43% over the past month. Looking at longer stretches, total return stands at 34.52% over the past year, 39.55% over the past 3 years and 21.35% over the...
NasdaqGS:WBTN
NasdaqGS:WBTNInteractive Media and Services

A Look At WEBTOON Entertainment (WBTN) Valuation After Q1 Results And New Revenue Guidance

WEBTOON Entertainment (WBTN) is back in focus after first quarter 2026 results showed sales of US$320.87 million, a smaller net loss, and fresh second quarter revenue guidance that sets expectations for the coming months. See our latest analysis for WEBTOON Entertainment. WEBTOON Entertainment's share price has climbed over the past month, with a 30 day share price return of 9.43% and a 90 day gain of 11.95%. The 1 year total shareholder return of 40.65% contrasts with a weaker year to date...
NYSE:SAM
NYSE:SAMBeverage

A Look At Boston Beer Company (SAM) Valuation After Soft Q1 Results And Lowered Analyst Price Targets

Boston Beer Company (SAM) has been under pressure after a softer first quarter, with revenue down 4.4% year on year and adjusted operating income missing analyst expectations. This has prompted investors to reassess demand and profitability. See our latest analysis for Boston Beer Company. The stock has been volatile around these results, with a 1-day share price return of 2.19% and a 7-day share price return of 8.80%. This follows a 30-day share price return that fell 19.59%, while the...
NYSE:DDS
NYSE:DDSMultiline Retail

Will Stronger Margins and EPS Shift Dillard’s (DDS) Narrative on Efficiency and Risk‑Reward Potential?

Dillard's, Inc. has reported past first-quarter 2026 results, with sales rising to US$1,568.4 million and net income reaching US$250.6 million, lifting basic and diluted earnings per share from continuing operations to US$16.04. The earnings release highlights that relatively modest sales and revenue growth translated into a much stronger profit outcome, suggesting improved operating efficiency and margin performance within the business. We will now examine how this sharp earnings...
NYSE:FOR
NYSE:FORReal Estate

The Bull Case For Forestar Group (FOR) Could Change Following Cautious Guidance And EBITDA Miss – Learn Why

Earlier this week, Forestar Group, the majority-owned land development subsidiary of D.R. Horton, reported quarterly results showing 6.6% year-on-year revenue growth, a narrow beat on adjusted operating income estimates, but an EBITDA miss alongside the weakest full-year guidance update in its peer group. The company’s cautious outlook contrasted with ongoing healthy demand for affordable single-family home lots and its solid liquidity position, raising fresh questions about how much of that...
NYSE:TEX
NYSE:TEXMachinery

What Terex (TEX)'s Analyst Upgrade and Margin Outlook Means For Shareholders

Earlier this week, Raymond James upgraded Terex Corporation to Strong Buy and Evercore ISI reaffirmed its positive stance, citing confidence in the company’s materials processing earnings and operational positioning despite elevated material and tariff costs. The fresh analyst commentary emphasizes Terex’s potential to use strong aggregates demand and pricing to help counter cost pressures and support margin improvement within its materials processing segment. Next, we’ll examine how this...
NasdaqGS:STEP
NasdaqGS:STEPCapital Markets

Crossing US$100 Million Fee Earnings Could Be A Game Changer For StepStone Group (STEP)

StepStone Group Inc. recently reported fourth-quarter 2026 revenue of US$588.58 million and a net loss of US$7.79 million, alongside full-year revenue of US$1.99 billion and a net loss of US$535.81 million, while also affirming a quarterly dividend of US$0.28 and declaring a special dividend of US$0.55 per share payable on June 30, 2026. The company also highlighted its first-ever quarter with more than US$100 million in fee-related earnings and record organic private wealth subscriptions,...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

How Investors Are Reacting To Chefs' Warehouse (CHEF) Board Vacancy Amid Positive Research View

In May 2026, The Chefs' Warehouse, Inc. reported that director Ivy Brown did not stand for reelection at the 2026 Annual Meeting, leaving her board seat temporarily vacant until a replacement is identified or the board size is reduced. At the same time, a positive research view from Zacks Investment Research highlighted Chefs' Warehouse as a growth-focused company, underpinned by strong projected earnings per share expansion and solid cash flow generation. We’ll now examine how Ivy Brown’s...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

The Bull Case For Fastenal (FAST) Could Change Following Mixed Q1 2026 Margins And Digital Progress

In the past few days, Fastenal released its Q1 2026 results showing 12.4% year-on-year revenue growth that aligned with analyst expectations but fell short of EBITDA estimates, drawing attention to cost and margin performance. The earnings reaction has reinforced the view that Fastenal is evolving beyond a cyclical fastener distributor, with its embedded FMI technology and on-site services making profitability and execution, rather than headline growth, the central focus for investors...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

A Look At Option Care Health (OPCH) Valuation After Legal Probe And Cut 2026 Revenue Guidance

Option Care Health (OPCH) is under legal scrutiny after Kirby McInerney LLP launched an investigation into alleged securities law violations following weaker first quarter 2026 results and a reduced full year revenue outlook. See our latest analysis for Option Care Health. The share price reaction has been sharp, with a 1 month share price return down 26.30% and a 3 month share price return down 42.01%, while the 5 year total shareholder return remains positive at 14.12%. This suggests recent...
NYSE:CC
NYSE:CCChemicals

Chemours (CC) Valuation In Focus As EPA Eases Refrigerant Rules And Policy Support Shifts

The EPA’s move to ease refrigerant regulations has put Chemours (CC) in focus, as investors weigh what weaker policy support could mean for demand and pricing of its next generation cooling products. See our latest analysis for Chemours. The share price has pulled back sharply in the last month, with a 1 month share price return of down 19.69% and a 7 day share price return of down 7.61%. This comes even though the year to date share price return is up 74.45% and the 1 year total shareholder...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Does Visteon (VC) Using Steady Dividends Amid Easing Auto Headwinds Reveal Its True Capital Priorities?

Earlier this month, Visteon Corporation's board declared a regular quarterly dividend of US$0.375 per share, payable on June 15, 2026 to shareholders of record as of June 1, 2026. This dividend decision arrives as easing Treasury yields and reduced concerns over fuel costs are improving expectations for vehicle affordability and demand across the auto industry. We’ll now examine how this dividend declaration, alongside improving auto demand expectations, may influence Visteon’s existing...
NYSE:CTS
NYSE:CTSElectronic

Does CTS (CTS) Boosted Dividend Reveal a Confident Capital Strategy or Limited Reinvention Options?

Earlier this month, CTS Corporation’s board declared a cash dividend of US$0.04 per share, payable on July 24, 2026 to shareholders of record as of June 26, 2026. The dividend decision comes as analysts and brokers maintain very positive views on CTS, reflecting confidence in its earnings estimates and operational outlook. With the new dividend and improving sentiment around industrial and transportation demand, we’ll now examine how this affects CTS’s investment narrative. AI is about to...
NasdaqGS:VIR
NasdaqGS:VIRBiotechs

Assessing Vir Biotechnology (VIR) Valuation After Hepatitis Delta Data Update And Astellas Oncology Partnership

Vir Biotechnology (VIR) is back in focus after announcing it will present Phase 2 SOLSTICE trial data for its tobevibart and elebsiran combination in chronic hepatitis delta at the upcoming EASL Congress 2026. See our latest analysis for Vir Biotechnology. The latest SOLSTICE update comes after a period of strong trading interest, with the share price at $9.19, a 90 day share price return of 23.69% and a 1 year total shareholder return of 104.22%. However, multi year total shareholder returns...
NYSE:MCB
NYSE:MCBBanks

Is It Too Late To Consider Metropolitan Bank Holding (MCB) After Its 44% One-Year Rally?

If you are wondering whether Metropolitan Bank Holding at around US$91 per share is still reasonably priced or already stretched, a closer look at its valuation tools can help frame that question. The stock has returned 4.7% over the past week, 3.6% over the last month, 18.5% year to date, and 44.4% over the past year, which will naturally raise questions about how much of the story is already reflected in the price. Recent coverage around Metropolitan Bank Holding has focused on its share...
NYSE:DBD
NYSE:DBDTech

Can Diebold Nixdorf’s New CIO (DBD) Reframe Its Long-Term Digital and Cybersecurity Strategy?

Earlier this month, Diebold Nixdorf appointed Raj Singh as executive vice president and CIO, succeeding retiring CIO Teresa Ostapower and tasking him with leading global IT and cybersecurity, including generative AI, cloud, ERP and analytics initiatives. This leadership change brings nearly three decades of cross-industry technology and digital transformation experience that could influence how effectively Diebold Nixdorf upgrades its infrastructure and supports its banking and retail...
NYSE:HTGC
NYSE:HTGCCapital Markets

How Alleged Due Diligence and Valuation Missteps Will Impact Hercules Capital (HTGC) Investors

In the past year, several law firms including Rosen Law Firm, Faruqi & Faruqi, and Grabar Law Office launched securities class actions and investigations alleging Hercules Capital overstated its due diligence, misclassified portfolio investments, and overstated portfolio valuations. These cases not only raise questions about prior disclosures to investors but also put Hercules Capital’s governance, valuation practices, and risk controls under heightened scrutiny. We’ll now examine how...
NYSE:KR
NYSE:KRConsumer Retailing

Is Kroger (KR) Pricing Look Interesting After Mixed Returns And Rich P/E Multiple?

Wondering if Kroger at US$67.25 is offering fair value or if you might be paying over the odds for those groceries in your portfolio? The stock has returned 1.9% over the last 7 days, 0.0% over the past 30 days, 6.8% year to date, 0.1% over 1 year, 51.9% over 3 years and 102.3% over 5 years, so the recent share price sits against a mixed backdrop of shorter and longer term results. Recent coverage has focused on Kroger's position in US consumer retailing, including ongoing scrutiny of its...
NYSE:LYV
NYSE:LYVEntertainment

Did Live Nation's New Spotify-Powered “Reserved” Tickets Just Recast LYV's Tech and Fan-Trust Narrative?

Live Nation Entertainment recently launched “Reserved,” a new ticketing access program for eligible Spotify Premium subscribers in the US, aiming to cut competition and stress in buying concert tickets without extra fees from Spotify. This collaboration highlights how Live Nation is experimenting with partner-driven ticket access to address fan frustration and rebuild trust around ticketing. Next, we’ll examine how the Reserved initiative with Spotify could influence Live Nation’s investment...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Is It Too Late To Consider Lantheus Holdings (LNTH) After Its Strong Share Price Run?

This article is designed to help you think through whether Lantheus Holdings, at around US$103, is still offering value or if most of the opportunity is already priced in. The stock has shown strong recent price action, with returns of 9.7% over the past week, 22.1% over the past month, 53.1% year to date, and 39.5% over the past year. Recent coverage has focused on Lantheus as a specialist in medical imaging and diagnostics, with investors closely watching how its product portfolio...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Intapp Expands AI Timekeeping As Shares Trade Below Analyst Targets

Intapp (NasdaqGS:INTA) has introduced new AI powered features in Intapp Time, focused on helping professional services firms manage time and revenue capture more efficiently. The latest release includes AI work code prediction, configurable narrative tone enforcement, and upgraded mobile timekeeping tools. The update expands the use of AI across Intapp's cloud product suite for professional services clients. Intapp operates in the professional services technology space, where firms depend...